AstraZeneca to Build $1.5b Cancer Drug Plant
AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish drugmaker has said. The facility,…
Read More



